Susquehanna International Group
AVNS icon

Susquehanna International Group’s Avanos Medical AVNS Stock Holding History

Susquehanna International Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,400
Closed -$276K – 10523
2020
Q2 		$276K Sell
9,400
-13,700
-59% -$397K ﹤0.01% 8495
2020
Q1 		$622K Buy
23,100
+12,900
+126% +$385K ﹤0.01% 6452
2019
Q4 		$344K Buy
+10,200
New +$369K ﹤0.01% 7749
2019
Q2 		– Sell
-11,000
Closed -$469K – 10191
2019
Q1 		$469K Buy
+11,000
New +$493K ﹤0.01% 6406
2018
Q4 		– Sell
-49,300
Closed -$3.38M – 8902
2018
Q3 		$3.38M Buy
49,300
+1,200
+2% +$77.2K ﹤0.01% 3194
2018
Q2 		$2.75M Sell
48,100
-3,900
-8% -$206K ﹤0.01% 3507
2018
Q1 		$2.4M Buy
52,000
+10,400
+25% +$494K ﹤0.01% 3592
2017
Q4 		$1.92M Buy
41,600
+3,700
+10% +$170K ﹤0.01% 3975
2017
Q3 		$1.71M Sell
37,900
-28,700
-43% -$1.22M ﹤0.01% 4198
2017
Q2 		$2.62M Buy
66,600
+22,700
+52% +$858K ﹤0.01% 3395
2017
Q1 		$1.67M Buy
43,900
+11,000
+33% +$429K ﹤0.01% 4054
2016
Q4 		$1.22M Sell
32,900
-10,500
-24% -$375K ﹤0.01% 5102
2016
Q3 		$1.5M Sell
43,400
-31,500
-42% -$1.1M ﹤0.01% 4042
2016
Q2 		$2.44M Buy
74,900
+43,700
+140% +$1.34M ﹤0.01% 3248
2016
Q1 		$896K Sell
31,200
-24,500
-44% -$653K ﹤0.01% 5299
2015
Q4 		$1.86M Sell
55,700
-24,600
-31% -$765K ﹤0.01% 4178
2015
Q3 		$2.28M Sell
80,300
-23,900
-23% -$834K ﹤0.01% 4018
2015
Q2 		$4.22M Buy
104,200
+26,800
+35% +$1.2M ﹤0.01% 3194
2015
Q1 		$3.81M Buy
77,400
+44,400
+135% +$2.06M ﹤0.01% 3145
2014
Q4 		$1.5M Buy
+33,000
New +$1.3M ﹤0.01% 5038

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Susquehanna International Group's AVNS Position: Q1 2026 in Review

Susquehanna International Group increased its Avanos Medical (AVNS) stake by 11% in Q1 2026, buying an estimated $23.9K and bringing the position to 18,512 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #11183.

Susquehanna International Group first reported a position in AVNS in Q4 2014 and has held it in 30 quarters since. The position peaked at $6.59M in Q1 2015. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Susquehanna International Group held 18,512 shares of Avanos Medical worth $259K as of Q1 2026.
  • Susquehanna International Group bought 1,776 Avanos Medical shares in Q1 2026, an estimated $23.9K.
  • Avanos Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11183 holding.
  • Susquehanna International Group first reported a position in Avanos Medical in Q4 2014 and has held it in 30 quarters since.
  • Susquehanna International Group's Avanos Medical position peaked at $6.59M in Q1 2015.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.